{
Nestlé S.A.

Companies

}
nestle india stock analysis suggests potential rally before further decline
Nestle India is currently experiencing a corrective phase, with potential upward movement towards 2500 before a downturn. The daily chart indicates a possible double top at 2785, while a recent drop through 2185 suggests a larger degree correction may be underway. Key resistance remains at 2785, with analysts predicting a rally towards 2440-50 before prices decline again.
FXStreet
Nestlé S.A. IND Harsh Japee
Finance & Economy, Market Report
13:25 18.12.2024
nestlé introduces protein shots to support weight loss drug users in us
Nestlé has launched protein shots in the US aimed at weight-loss drug users, designed to suppress appetite by mimicking the GLP-1 hormone response. The Boost Pre-Meal Hunger Support shake, containing whey protein and low calories, is intended to be consumed before meals and is priced at $10.99 per pack. While it may enhance satiety, experts question its long-term effectiveness compared to traditional weight loss methods.
Checkout
United States Dollar Nestlé S.A. Novo Nordisk A/S Amazon.com, Inc. Walmart Inc. Eli Lilly and Company USA CHE Stefan Palzer Lora Heisler Show more
Healthcare, Market Report
13:01 18.12.2024
coffee prices surge amid climate challenges and supply concerns
Indian coffee brands are raising prices, with Nestle implementing its fourth price hike, leading to increased costs for instant coffee. Supply risks, exacerbated by heavy rains and droughts, are driving global coffee prices higher, while Arabian coffee levels reach their highest since 1977.
summary_large_image
United States Dollar Nestlé S.A. IND Praveen Jaipuriar
Finance & Economy, News Article
12:57 18.12.2024
nestlé launches hunger support snack to compete with weight-loss drug demand
Nestlé's Boost Pre-Meal Hunger Support, a protein shot designed to suppress appetite, aims to compete with the booming weight-loss drug market, projected to reach $150bn annually. Utilizing patented whey protein micro-gels, it enhances GLP-1 hormone release, offering a cost-effective alternative to expensive medications like Wegovy. This strategic shift reflects the food industry's adaptation to changing consumer needs, emphasizing functionality and health-driven solutions.
BakeryAndSnacks.com
United States Dollar Nestlé S.A. CHE Stefan Palzer Lora Heisler
Healthcare, Market Report
12:09 18.12.2024
switzerland withdraws mf n status for india but nestle india unaffected
Switzerland has withdrawn the Most Favoured Nation (MFN) status granted to India following a Supreme Court ruling affecting Nestlé and other companies. Nestlé India stated that this decision will not impact its operations, as it has been deducting a 10% withholding tax. The Swiss authorities noted that the ruling highlighted a lack of reciprocity regarding the Double Taxation Avoidance Agreement, leading to higher tax demands on dividends for Swiss and other multinational companies.
BusinessLine
United States Dollar Nestlé S.A. CHE IND Kamal Narang Suresh Narayanan
Regulatory & Legal, News Article
11:09 18.12.2024
coffee prices surge as nestle and continental coffee implement multiple hikes
Coffee prices are on the rise as Nestle and Continental Coffee implement multiple hikes this year, impacting consumers significantly. Nestle's 45-gram jar has increased from Rs 180 to Rs 230, while the 90-gram jar rose from Rs 350 to Rs 440. The surge is attributed to rising Arabica bean prices, driven by adverse weather in Brazil and Vietnam, alongside increased input costs for both companies.
summary_large_image
United States Dollar CCL Products (India) Limited Nestlé S.A. BRA VNM IND Show more
Finance & Economy, News Article
09:58 18.12.2024
nestle launches protein shots to support weight loss and curb hunger
Nestle has launched protein shots in the U.S. aimed at weight-loss drug users, designed to suppress appetite by mimicking the GLP-1 hormone. The Boost Pre-Meal Hunger Support drink, containing whey protein and low calories, is intended to be consumed before meals and may help maintain weight loss. While it could enhance GLP-1 release, experts suggest similar effects might be achieved with regular foods like milk.
@bsindia
United States Dollar Eli Lilly and Company Walmart Inc. Novo Nordisk A/S Nestlé S.A. USA CHE Stefan Palzer Lora Heisler Show more
Healthcare, News Article
09:15 18.12.2024
global meal replacement shake market trends and growth outlook to 2028
The global meal replacement shake market is experiencing significant growth, driven by lifestyle changes and an increasing working population. Key players like Nestle and GlaxoSmithKline are innovating with new flavors and formulations, catering to rising consumer demand for weight management and organic options. The market is expected to expand further, particularly in North America, as meal replacement shakes become a popular alternative to fast food.
openPR.com
Abbott Laboratories Nestlé S.A. GLAXOSMITHKLINE CAPITAL PLC 4.0 Craig Francis Show more
Finance & Economy, Market Report
08:59 18.12.2024
Swiss Stock Market Set to Open Lower Ahead of Fed Decision and Inflation Data
The Swiss stock market is set to open lower, with the SMI index down 0.24% ahead of the US Federal Reserve's monetary policy decision and UK inflation data. Analysts anticipate a 25 basis point rate cut from the Fed, despite concerns over inflation in a strong US economy. Roche is slightly up after receiving a CE mark for a new testing device, while Dätwyler faces a significant loss due to a restructuring plan.
Zonebourse
British Pound Sterling United States Dollar Swiss Franc Hoffmann-La Roche AG Novartis AG Cembra Money Bank AG SGS SA Nestlé S.A. CHE Jean-Daniel Dätwyler Ipek Ozkardeskaya Jerome Powell Show more
Finance & Economy, Market Report
08:46 18.12.2024
Nestle introduces protein shots to support weight loss efforts in the US
Nestle has launched protein shots in the U.S. aimed at weight-loss drug users, designed to suppress appetite by mimicking the GLP-1 hormone. The Boost Pre-Meal Hunger Support drink, containing 10 grams of whey protein and 45 calories, is intended to be consumed before meals and is priced at $10.99 for a pack of four. While it may enhance GLP-1 release, experts question its long-term effectiveness compared to traditional weight-loss medications.
Khaleej Times
United States Dollar Eli Lilly and Company Walmart Inc. Novo Nordisk A/S Nestlé S.A. CHE Stefan Palzer Lora Heisler Show more
Healthcare, News Article
07:35 18.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Central Bank Actions Banking Regulations Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Mergers & Acquisitions Cryptocurrency & Blockchain Regulations Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Emerging Startups Cryptocurrency Regulations Inflation Rates & CPI Data SEC & Financial Compliance Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN CHN IND SGP DNK CAN NGA FIN COL AUT VGB LIE TUR
Companies:
Credit Suisse Real Estate Fund Siat BlackRock, Inc. Coinbase Global, Inc. Solana USD Ethereum USD Ripples USD Tesla, Inc. Fidelity Contrafund Cardano USD Apple Inc. NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc End Federal Reserve USD MicroStrategy Incorporated Crypto.com Staked ETH USD
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Thomas Jordan Gary Gensler Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.